The path forward requires a commitment to innovation, a focus on equitable access, and a collaborative spirit to navigate the challenges and unlock the full potential of GLP-1 receptor agonists
Steps to Follow After an Ozempic, Wegovy, Rybelsus, Mounjaro, or Trulicity Injury If you suspect that you have been harmed by Ozempic, Rybelsus, Wegovy, Mounjaro, or Trulicity, it is important to act quickly
GLP-1s may be a worthwhile investment, but their value depends on how they are implemented and supported
Epidemiological studies reported an almost two-fold increased risk for infected individuals to develop CRC, but only recently, direct causal and functional links between the chronic infection and CRC have been revealed
The most common starting point is 250 mcg twice daily, totaling 500 mcg per day